Lobo M, Patel J, Kamins G, Francis R, Breza B, Jerzewski R
Bristol-Myers Squibb, Pharmaceutical Research Institute, New Brunswick, NJ 08903, USA.
Int J Pharm. 2007 Jul 18;339(1-2):168-74. doi: 10.1016/j.ijpharm.2007.02.032. Epub 2007 Mar 4.
The purpose of this study was to identify the mechanism(s) of omapatrilat degradation observed during dissolution from modified release (MR) tablet formulations containing colorants. The tablets were manufactured by a dry granulation process employing roller compaction. The colorants were added intragranularly and included red and yellow iron oxides and FD&C Blue No. 2 lake and dye. Dissolution studies in pH 6 or 6.8 media do not indicate any omapatrilat degradation in the absence of colorants. In the presence of colorants the degradation rate of omapatrilat in pH 6.8 media was in the following order: blue lake>blue lake+yellow iron oxide>yellow and red iron oxides. Higher degradation was observed with MR tablets formulated with indigo carmine (dye) as opposed to tablets formulated with aluminum oxide or aluminum hydroxide (dye substrate portion of lake). The inclusion of tartaric acid and the photostabilizer, uric acid, in omapatrilat MR tablets containing the blue lake reduced the degradation significantly. The dissolution instability observed at pH 6.8 in the MR tablet formulated with FD&C Blue No. 2 Lake was attributed to the dye component of the lake. The instability was more pronounced at higher pH and in the absence of a photostabilizer.
本研究的目的是确定在含有着色剂的缓释(MR)片剂制剂溶出过程中观察到的奥帕曲拉降解机制。这些片剂采用滚压法干法制粒工艺制造。着色剂在颗粒内添加,包括红色和黄色氧化铁以及FD&C蓝2号色淀和染料。在pH 6或6.8介质中的溶出研究表明,在没有着色剂的情况下,没有奥帕曲拉降解。在有着色剂存在的情况下,奥帕曲拉在pH 6.8介质中的降解速率顺序如下:蓝色色淀>蓝色色淀+黄色氧化铁>黄色和红色氧化铁。与用氧化铝或氢氧化铝(色淀的染料底物部分)制成的片剂相比,用靛蓝胭脂红(染料)制成的MR片剂观察到更高的降解。在含有蓝色色淀的奥帕曲拉MR片剂中加入酒石酸和光稳定剂尿酸可显著降低降解。在含有FD&C蓝2号色淀的MR片剂中,在pH 6.8观察到的溶出不稳定性归因于色淀的染料成分。在较高pH值且没有光稳定剂的情况下,这种不稳定性更为明显。